Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | F11 | P03951 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | HPSE | Q9Y251 | 8/20 | 0.33 |
| ▸ | FGF1 | P05230 | 6/20 | 0.33 |
| ▸ | FGF2 | P09038 | 6/20 | 0.33 |
| ▸ | ANTXR2 | P58335 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | VEGFA | P15692 | 3/20 | 0.33 |
| ▸ | TLR4 | O00206 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6223743 | 1.00 | CYP2D6 (0.36) | CYP2D6THRBHSD17B10F11CA2 | |
| SCHEMBL6218235 | 0.83 | CYP2D6 (0.40) | CYP2D6THRBHSD17B10F11CA2 | |
| SCHEMBL6216706 | 0.83 | CYP2D6 (0.40) | CYP2D6THRBHSD17B10F11CA2 | |
| SCHEMBL6216705 | 0.83 | CYP2D6 (0.40) | CYP2D6THRBHSD17B10F11CA2 | |
| SCHEMBL6218238 | 0.83 | CYP2D6 (0.40) | CYP2D6THRBHSD17B10F11CA2 | |
| SCHEMBL6218293 | 0.82 | CYP2D6 (0.55) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL27055962 | 0.82 | CYP2D6 (0.55) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL22201720 | 0.82 | CYP2D6 (0.55) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL6218292 | 0.82 | CYP2D6 (0.55) | CYP2D6THRBHSD17B10CA2CA12 | |
| SCHEMBL6220367 | 0.82 | CYP2D6 (0.35) | CYP2D6THRBHSD17B10F11CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6831164-B2 | Generation of peracylated 1-O-glycosides; obtain chemical intermediate, react with alkylating agent, heat and recover product | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-12-14 | — | — | US | claimed |
| EP-1404691-B1 | METHOD FOR PRODUCING PERACYLATED 1-O-GLYCOSIDES | SCHERING AG (DE) | 2005-03-09 | — | — | EP | disclosed |
| US-6831164-B2 | Generation of peracylated 1-O-glycosides; obtain chemical intermediate, react with alkylating agent, heat and recover product | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-12-14 | — | — | US | disclosed |
| US-20030069402-A1 | Process for the production of peracylated 1-0-glycosides | SCHERING AG (DE) | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069402-A1 | Process for the production of peracylated 1-0-glycosides | B3GNT2, UGT8, UGGT1 | CYP2D6 974/4885THRB 1204/4885HSD17B10 106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.